148.67
148.67 (0%)
As of Apr 17, 2025
Zoetis Inc. [ZTS]
Source:
Company Overview
Zoetis Inc. is a global leader in the animal health industry, focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health.
| Country | United States |
| Headquarters | parsippany, new jersey |
| Phone Number | (973)-822-7000 |
| Industry | manufacturing |
| CEO | Kristin C. Peck |
| Website | www.zoetis.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $2,361 |
| Operating Profit | |
| Net Income | $624 |
| Net Cash | $-467 |
Profit Ratios
| Gross Margin | $1,693 |
| Operating Margin | |
| Profit as % of Revenues | 271.3% |
| Profit as % of Assets | 7.6% |
| Profit as % of Stockholder Equity | 12.6% |
Management Effectiveness
| Return on Equity | 12.6% |
| Return on Assets | 4.4% |
| Turnover Ratio | 28.6% |
| EBITA | $35 |
Balance Sheet and Cash Flow Measures
| Total Assets | $14,165 |
| Total Liabilities | $9,205 |
| Operating Cash Flow | $1,097 |
| Investing Cash Flow | $-263 |
| Financing Cash Flow | $-1,287 |
